Status:
COMPLETED
An Explanatory Factors Analysis of Inflammatory Bowel Diseases(IBD's) Management Costs for Adults Patients Treated by Biotherapy and Followed at Nancy University Hospital
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
HEVA - Lyon
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to analyze the factors influencing the medical and non-medical direct costs of patients treated with biotherapy during the last twelve months (infliximab or adalimumab),...
Eligibility Criteria
Inclusion
- Patients consulted at the Gastroenterology services of Nancy University Hospital during the period of inclusion
- Patients over 18 of age the day of consultation
- Patients treated at least one time by biotherapy during the last 12 months preceeding inclusion
- Patients with crohn's disease or ulcerative colitis.
- Patients accepting to respond to the questionnary
Exclusion
- Age under 18 years , the day of consultation
- Patient that not accept or unable to complete the retrospective questionnary
Key Trial Info
Start Date :
November 28 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2017
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT03248024
Start Date
November 28 2016
End Date
February 7 2017
Last Update
August 14 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.